Camden National director granted 919 CAC shares

McCarthy Marie J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

McCarthy Marie J reported acquisition or exercise transactions in this Form 4 filing.

Camden National Corp director Marie J. McCarthy received a grant of 919 shares of Common Stock on June 1, 2026 as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and its amendment, at no cash cost to her.

The shares vested immediately on the grant date. After this grant and prior dividend reinvestments, McCarthy directly holds a total of 16,941.818 Camden National Corp shares, including 275.647 shares accumulated through the company’s dividend reinvestment program since her last filing.

Insider Trade Summary

Grant/Award: 919 shares

Grant/Award 1 txn

Insider McCarthy Marie J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	919	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,941.818 shares (Direct)

Footnotes (2)

1. F1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.
2. F2. Includes 275.647 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Key Figures

Equity grant size: 919 shares Grant price: $0.0000 per share Total holdings after transaction: 16,941.818 shares +2 more

5 metrics

Equity grant size 919 shares Common Stock grant to director on June 1, 2026

Grant price $0.0000 per share Compensation grant under Independent Directors' Equity Compensation Program

Total holdings after transaction 16,941.818 shares Director’s direct ownership following the grant

Dividend reinvestment shares 275.647 shares Accumulated since last filing via dividend reinvestment program

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Independent Directors' Equity Compensation Program, 2022 Equity and Incentive Plan, dividend reinvestment program, Form 4

4 terms

Independent Directors' Equity Compensation Program financial

"Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan"

2022 Equity and Incentive Plan financial

"a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A."

dividend reinvestment program financial

"Includes 275.647 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program."

A dividend reinvestment program lets investors automatically use cash dividends to buy more shares of the same company instead of taking the money as cash. Think of it like an automatic savings plan that turns small payouts into additional ownership, often including fractional shares, which can speed up compound growth and reduce the need for manual buying decisions — a convenience that can boost long-term returns for shareholders.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Camden National Corp (CAC) director Marie J. McCarthy report in this Form 4?

Director Marie J. McCarthy reported receiving 919 shares of Camden National Corp Common Stock as an equity grant. The award was made at no cash cost under the Independent Directors' Equity Compensation Program and vested immediately on the grant date.

How many Camden National Corp (CAC) shares did Marie J. McCarthy receive and at what price?

Marie J. McCarthy received 919 shares of Camden National Corp Common Stock in this transaction. The reported price per share was 0.0000, reflecting a compensation grant rather than an open-market purchase for cash consideration.

What is Marie J. McCarthy’s total Camden National Corp (CAC) shareholding after this grant?

Following the 919-share equity grant, Marie J. McCarthy directly holds 16,941.818 shares of Camden National Corp. This total includes shares acquired previously, such as those accumulated through participation in the company’s dividend reinvestment program.

Did the Camden National Corp (CAC) director’s grant vest immediately?

Yes, the 919-share grant to director Marie J. McCarthy vested immediately on the date of grant. The footnotes state that all shares under the Independent Directors' Equity Compensation Program vested at once when awarded on June 1, 2026.

How many Camden National Corp (CAC) shares did Marie J. McCarthy gain through dividend reinvestment?

The filing notes that 275.647 shares were acquired since the last filing through Camden National Corp’s dividend reinvestment program. These reinvested dividends increased her direct holdings in addition to the new 919-share equity grant.

Is this Camden National Corp (CAC) Form 4 a market buy or a compensation grant?

This Form 4 reflects a compensation-related equity grant, not a market purchase. The 919 shares were granted under the Independent Directors' Equity Compensation Program at a reported price of 0.0000 per share, indicating no cash outlay by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCarthy Marie J

(Last) (First) (Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		919	A	$0(1)	16,941.818(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

2. Includes 275.647 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Remarks:

	Christopher G. Hutchinson, POA	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)